Many women are surprised to learn that their cholesterol has risen during perimenopause or menopause, even when nothing has changed in their diet or lifestyle.
The conversation that follows is often focused on one number:
“Your LDL is high.”
But LDL cholesterol is far more complex than a single value on a blood test. Understanding its nuances can provide clarity, reduce fear, and help guide more effective support strategies during midlife.
Most standard blood tests report LDL as a single number, but LDL actually refers to a family of particles, each with different characteristics and risks.
The two major subtypes are:
small, dense LDL
large, buoyant LDL
Why does this matter?
Because their behaviour in the body is very different.
Small, dense LDL
More likely to:
penetrate the arterial wall
oxidise
contribute to plaque formation
associate with inflammation
correlate with insulin resistance
Large, buoyant LDL
More likely to:
circulate without embedding in arterial walls
be cleared efficiently
show lower association with cardiovascular events
Yet most women are never told which type they have.
As oestrogen declines, several physiological changes occur:
liver metabolism shifts
cholesterol production increases
cell membranes become less flexible
inflammation rises
insulin sensitivity decreases
triglycerides often increase
For many women, LDL changes reflect hormonal and metabolic adaptation, not simply dietary intake.
This is why an LDL increase during menopause can sometimes be a more reliable indicator of menopausal transitionthan fluctuating hormone levels.
Beyond size, the pattern of LDL changes is highly informative.
Two common patterns emerge:
Pattern A
Large, buoyant LDL
Generally lower risk
Pattern B
Small, dense LDL
Often linked with:
insulin resistance
metabolic syndrome
high triglycerides
abdominal fat distribution
chronic inflammation
Menopause increases the likelihood of shifting toward Pattern B due to metabolic changes.
One of the most useful LDL nuances is the relationship between:
triglycerides and HDL
A pattern of:
high triglycerides
low HDL
is a stronger predictor of cardiovascular risk than LDL alone.
This pattern is influenced by:
blood sugar instability
stress
poor sleep
alcohol
abdominal fat
inflammation
All common challenges during menopause.
LDL becomes more concerning when combined with:
chronic inflammation
oxidative stress
endothelial damage
Without inflammation, LDL behaves differently.
This is one reason why focusing solely on lowering LDL may not address the underlying drivers of cardiovascular risk.
When LDL changes are viewed without context, women often feel:
frightened
judged
pressured into medication discussions
confused about what to do next
Understanding LDL nuances helps reframe the conversation from:
“Your cholesterol is high.”
to:
“What is driving this pattern, and what support does your body need?”
More detailed lipid testing can provide:
LDL particle size
LDL particle number
triglyceride patterns
insulin resistance markers
inflammation status
These insights can guide more personalised and effective strategies.
LDL cholesterol is not inherently “good” or “bad.”
For midlife women, the most important questions are:
What type of LDL is present?
What is happening with triglycerides and HDL?
Is inflammation driving risk?
How is metabolic health shifting during menopause?
Understanding these nuances provides a clearer, more empowering picture of cardiovascular health.
In clinic, I see many women distressed by changes in their LDL levels. Once we explore the broader context—hormones, metabolism, inflammation, triglycerides—the path forward becomes clearer and far less frightening.
Supporting cardiovascular health during menopause requires a whole-body approach, not just chasing a number.
If you’d like help interpreting your cholesterol results or understanding what your body may be signalling, I’d love to support you.
Other cholesterol references
Why Cholesterol Rises With Menopause
Interview with Dr Jonny Bowden - Youtube (also podcast # 150)